Optimizing resuscitation of the donation after circulatory death (DCD) heart by mitochondrial redox regulation and opioid receptor activation: a protocol for clinical application

通过线粒体氧化还原调节和阿片受体激活优化循环死亡（DCD）心脏捐赠的复苏：临床应用方案

• 批准号: 418895
• 负责人: Zaugg Michael
• 金额: $ 52.11万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-03-01 至 2025-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=418895&lang=en
• 关键词: Anesthetic Cardioprotection; Cardiac Transplant Surgery; Damage Associated Molecular Patterns (Damps); Donation After Circulatory Death (Dcd); Mitochondria

Few therapies are available to patients who are suffering end-stage heart failure. Cardiac transplantation remains the gold-standard therapeutic intervention for those patients with end-stage heart failure. Donation after Circulatory Death or DCD means th

患有终末期心力衰竭的患者几乎没有可用的治疗方法。心脏移植仍然是终末期心力衰竭患者的金标准治疗干预措施。循环性死亡或DCD后献血意味着